NASDAQ:MNOV - MediciNova, Inc.
$9.51
 $-0.20
-2.06%
12:50PM EDT
2019-07-22
Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029 (denibulin). MN-166 is an oral, anti-inflammatory and neuroprotective agent. MN-166 is in development for the treatment of several neurological diseases, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, and substance dependence and addiction. MN-001 (tipelukast) is an orally bioavailable small molecule compound, which is used for the treatment of fibrotic diseases, such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. MN-221 treats acute exacerbations of asthma through intravenous infusion, bypassing constricted airways to deliver the drug to the lungs. MN-029 is used for the treatment of solid tumor cancers. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MNOV     avg for
industry  
  avg for
sector  
42 stocks weight:  23. 36   217. 37   399. 45  
42 stocks rank:  3. 06 K 1. 27 K 716. 99  
# analyst opinions:  2. 00   13. 21   13. 71  
mean recommendation:  1. 50   2. 10   2. 04  

quick ratio:  46. 00   5. 49   1. 88  
current ratio:  46. 40   5. 87   2. 36  

target price low:  18. 00   83. 44   114. 90  
target price avg:  20. 00   106. 20   137. 90  
target price high:  22. 00   132. 30   158. 97  
1-yr high:  13. 22   111. 86   142. 57  
last close:  9. 71   86. 79   125. 44  
50-day avg:  10. 32   86. 68   122. 63  
200-day avg:  9. 74   89. 22   121. 38  
1-yr low:  6. 82   69. 78   100. 51  
volume:  43. 54 K 2. 62 M 3. 43 M
50-day avg volume:  135. 43 K 3. 20 M 4. 16 M
200-day avg volume:  96. 46 K 2. 99 M 4. 75 M

1-day return:  0. 73 % -1. 30 % -0. 99 %
this week return:  -6. 81 % 0. 45 % -0. 20 %
12-wk return:  -11. 32 % 0. 94 % 4. 84 %
52-wk return:  8. 29 % -1. 30 % 10. 55 %

enterprise value (EV):  353. 54 M 45. 10 B 122. 38 B
market cap:  418. 14 M 38. 96 B 108. 40 B
EBITDA:  -15. 87 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -22. 27   5. 38   11. 93  
total debt:  348. 22 K 10. 90 B 17. 48 B
debt/equity:  0. 46   57. 18   120. 05  
net income (common):  -14. 83 M 2. 07 B 4. 05 B

shares outstanding:  0. 00   538. 09 M 1. 24 B
shares:  39. 43 M 548. 00 M 1. 22 B
shares short:  3. 63 M 10. 98 M 11. 87 M
shares short prior month:  3. 69 M 9. 32 M 12. 05 M
short ratio:  26. 50   5. 60   3. 34  
short % of float:  8. 91 % 6. 48 % 2. 64 %
total cash/share:  1. 47   10. 98   9. 19  
total cash:  63. 21 M 5. 93 B 6. 10 B
free cash flow:  -3. 27 M 2. 92 B 4. 55 B
operating cash flow:  -8. 06 M 3. 80 B 5. 78 B

book value:  1. 74   13. 35   27. 45  
price/book:  5. 57   4. 60   8. 78  
operating margins:  0. 00 % -308. 40 % -28. 55 %
EBITDA margins:  0. 00 % 13. 17 % 23. 38 %
profit margins:  0. 00 % 10. 44 % 14. 18 %
gross margins:  0. 00 % 35. 80 % 55. 40 %

1-yr max volatility:  16. 66 % --- ---
1-yr mean volatility:  3. 18 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 35   2. 10   4. 23  
forward EPS:  -0. 78   3. 45   7. 10  
P/E:  -27. 51   1. 90   32. 10  
forward P/E:  -12. 36   6. 46   15. 47  
PE/G:  8. 54   0. 70   -0. 54  
growth:  -3. 22 % 265. 63 % 79. 11 %
earnings high:  -0. 10   0. 89   1. 68  
earnings avg:  -0. 12   0. 70   1. 57  
earnings low:  -0. 14   0. 46   1. 46  
revenue high:  -0. 00   2. 57 B 11. 07 B
revenue avg:  -0. 00   2. 51 B 10. 91 B
revenue low:  -0. 00   2. 45 B 10. 73 B
return on assets:  -12. 64 % -2. 34 % 5. 28 %
return on equity:  -19. 69 % -90. 08 % 133. 53 %

beta (1yr vs S&P500):  1. 67   1. 27   0. 91  
sharpe (1yr):  0. 53   0. 16   0. 77  

held % insiders:  10. 29 % 6. 06 % 3. 29 %
held % institutions:  22. 00 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MNOV
.    111.595 =       111.595 :: --> INITIAL WEIGHT <--
.    - 0.353 =       111.242 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.625 =       292.003 :: P/E factor
.    x 0.849 =       247.968 :: PE/G factor
.    x 1.495 =       370.801 :: beta factor
.     x 0.83 =       307.683 :: sharpe factor
.    x 5.597 =       1722.07 :: current ratio factor
.    x 1.011 =      1741.099 :: quick ratio factor
.    x 1.019 =      1773.646 :: short ratio factor
.    x 1.068 =      1894.703 :: price-to-book factor
.    x 1.004 =      1902.375 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      4034.543 :: sector+industry 1-year gains factor
.    x 1.009 =      4072.581 :: industry 12-weeks return factor
.    x 1.308 =      5326.482 :: industry 2-weeks return factor
.    x 1.138 =      6063.323 :: company one-year gains+dividend factor
.    x 3.212 =     19475.908 :: company 13 weeks' performance factor
.     x 1.03 =     20065.386 :: 5-day avg > 200-day avg
.     x 1.06 =     21269.208 :: 50-day avg > 200-day avg
.    x 0.976 =     20748.681 :: "drift" penalty 3 days ago
.    / 2.037 =     10188.185 :: overall "drift" factor
.    x 0.834 =      8495.405 :: largest single-day jump factor
.    x 0.134 =       1137.27 :: low price factor
.    x 0.698 =       794.006 :: notable returns + performance factor
.    x 3.374 =      2678.992 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.608 =      1629.899 :: forward EPS factor
.    x 0.858 =      1397.965 :: forward P/E factor
.    x 1.185 =      1656.186 :: industry recommendation factor
.     x 2.42 =      4007.577 :: company recommendation factor
.    x 1.003 =      4018.659 :: factor historical industry gain for week 29
.    x 2.146 =      8625.698 :: target low factor
.    x 1.343 =     11585.557 :: target mean factor
.    x 1.047 =     12132.992 :: target high factor
.   x 11.252 =    136525.563 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        19.222 :: reduced for readability
.    + 2.549 =        21.772 :: add/subtract for investor sentiment
.    + 1.591 =        23.362 :: earnings report in 3 days
.                               --> FINAL WEIGHT <--
.                     23.362 :: FINAL WEIGHT for NASDAQ:MNOV


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org